Loading organizations...
§ Private Profile · Nashville, IL, USA
Oncology enablement platform supporting value-based care for community oncology practices, assuming medical cost risk.
Atlas Oncology Partners is a healthcare organization based in the United States that operates a value-based oncology enablement platform designed to embed interdisciplinary care teams directly into independent community oncology practices. The company assumes full medical cost risk in arrangements with payers to coordinate comprehensive patient care, including psychosocial support and proactive treatment navigation. To support its geographic expansion and infrastructure development, the enterprise secured $28 million in Series A funding during 2023. This financing round was led by Flare Capital Partners, with additional equity participation from the firm's initial founding investor, Rubicon Founders. The organization's strategic direction is supported by key institutional investors, including Ian Chiang of Flare Capital Partners and Matt Kim of Rubicon Founders. To align financial incentives with clinical outcomes and simplify fragmented cancer care delivery, Atlas Oncology Partners was founded by Kate Roberts.
Atlas Oncology Partners has raised $28.0M across 1 funding round.
Atlas Oncology Partners has raised $28.0M in total across 1 funding round.
Atlas Oncology Partners has raised $28.0M across 1 funding round. Most recently, it raised $28.0M Series A in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 11, 2026 | $28M Series A | Flare Capital Partners | Rubicon Founders | Announced |
Atlas Oncology Partners has raised $28.0M in total across 1 funding round.
Atlas Oncology Partners's investors include Flare Capital Partners, Rubicon Founders.